Expression data of A224 cell with ectopic overexpression of FGF18 and RFP

We have identified the overexpression of FGF18 as an independent predictive marker for poor clinical outcome in patients with advanced stage, high-grade serous ovarian cancer. Functional studies have demonstrated that FGF18 promotes migration, invasion and tumorigenicity of ovarian cancer cells in vitro and in vivo.

6

Wei W, Mok SC, Oliva E, Kim SH, Mohapatra G, Birrer MJ